Literature DB >> 9855710

Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells.

Y Fukushima1, Y Oshika, M Nakamura, T Tokunaga, H Hatanaka, Y Abe, H Yamazaki, H Kijima, Y Ueyama, N Tamaoki.   

Abstract

Human histocompatibility leukocyte antigen (HLA)-G is a nonclassical major histocompatibility complex class I molecule. HLA-G is known to provide tolerance from recognition by natural killer cells. We studied HLA-G expression in 39 human colorectal cancers and 23 extra-neoplastic colon tissue samples by RT-PCR. The expression of HLA-G mRNA was significantly more frequent in colorectal cancer (34 of 39 cases) than in the extraneoplastic tissue (10 of 23 specimens; chi2 test, p = 0.0003). HLA-G expression was also confirmed on the cancer cells immunohistochemically. These results suggested that HLA-G on colorectal cancer cells may be correlated with escape from immunological surveillance during colon cancer development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9855710     DOI: 10.3892/ijmm.2.3.349

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  17 in total

1.  HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract.

Authors:  Donna E Hansel; Ayman Rahman; Robb E Wilentz; Ie-ming Shih; Michael T McMaster; Charles J Yeo; Anirban Maitra
Journal:  Int J Gastrointest Cancer       Date:  2005

Review 2.  HLA-G regulators in cancer medicine: an outline of key requirements.

Authors:  Ines Zidi; Nidhal Ben Amor
Journal:  Tumour Biol       Date:  2011-07-27

3.  Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production.

Authors:  M Urosevic; M O Kurrer; J Kamarashev; B Mueller; W Weder; G Burg; R A Stahel; R Dummer; A Trojan
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

4.  Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines.

Authors:  E C Ibrahim; M Morange; J Dausset; E D Carosella; P Paul
Journal:  Cell Stress Chaperones       Date:  2000-07       Impact factor: 3.667

Review 5.  Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?

Authors:  Laurence Amiot; Soldano Ferrone; Hans Grosse-Wilde; Barbara Seliger
Journal:  Cell Mol Life Sci       Date:  2010-11-10       Impact factor: 9.261

6.  HLA-G as a prognostic marker in stage II/III colorectal cancer: not quite there yet.

Authors:  Federica Grillo; Luca Mastracci; Alessandro Gambella; Stefano Scabini; Gabriele Zoppoli; Annalisa De Silvestri; Simona Pigozzi; Michele Paudice; Michela Campora; Roberto Fiocca
Journal:  Histochem Cell Biol       Date:  2022-07-28       Impact factor: 2.531

7.  Diagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer/T-Cell Lymphoma.

Authors:  Can Küçük; Xiaozhou Hu; Qiang Gong; Bei Jiang; Adam Cornish; Philippe Gaulard; Timothy McKeithan; Wing C Chan
Journal:  Am J Pathol       Date:  2016-04-07       Impact factor: 4.307

Review 8.  Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond.

Authors:  Marica Garziera; Giuseppe Toffoli
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

Review 9.  Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association.

Authors:  Eduardo A Donadi; Erick C Castelli; Antonio Arnaiz-Villena; Michel Roger; Diego Rey; Philippe Moreau
Journal:  Cell Mol Life Sci       Date:  2010-11-24       Impact factor: 9.261

10.  Prognostic and Clinicopathological Value of Human Leukocyte Antigen G in Gastrointestinal Cancers: A Meta-Analysis.

Authors:  Yongjia Peng; Jian Xiao; Wenyun Li; Shuna Li; Binbin Xie; Jiang He; Chaoqun Liu
Journal:  Front Oncol       Date:  2021-05-12       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.